TLR9 agonists: Immune mechanisms and therapeutic potential in domestic animals

Veterinary Immunology and Immunopathology

Volumn 148, Issue 1-2, 2012, Pages 85-89

  Mutwiri, George ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Adjuvants; Animals; CpG ODN; Immune mechanisms; Immunotherapy; TLR9; Vaccines

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; GAMMA INTERFERON; INTERLEUKIN 12; TOLL LIKE RECEPTOR 9;

ADAPTIVE IMMUNITY; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; CELL ACTIVATION; CYTOKINE RESPONSE; ESCHERICHIA COLI; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOTHERAPY; INFECTION; INFECTION PREVENTION; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; NONHUMAN; PARAINFLUENZA VIRUS 3; PROTEIN EXPRESSION; SALMONELLA ENTERITIDIS; SALMONELLA TYPHIMURIUM; SWINE INFLUENZA VIRUS; VIRUS LOAD;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANIMALS, DOMESTIC; IMMUNITY, INNATE; OLIGODEOXYRIBONUCLEOTIDES; TOLL-LIKE RECEPTOR 9;

ANIMALIA; MAMMALIA; RODENTIA;

EID: 84864152574     PISSN: 01652427     EISSN: 18732534     Source Type: Journal    
DOI: 10.1016/j.vetimm.2011.05.032     Document Type: Article

References (56)

1. Alcon V.L., Foldvari M., Snider M., Willson P., Gomis S., Hecker R., Babiuk L.A., Baca-Estrada M.E. Induction of protective immunity in pigs after immunisation with CpG oligodeoxynucleotides formulated in a lipid-based delivery system (Biphasix). Vaccine 2003, 21:1811-1814.
2. Ashkar A.A., Bauer S., Mitchell W.J., Vieira J., Rosenthal K.L. Local delivery of CpG oligodeoxynucleotides induces rapid changes in the genital mucosa and inhibits replication, but not entry, of herpes simplex virus type 2. J. Virol. 2003, 77:8948-8956.
3. Booth J.S., Buza J.J., Potter A., Babiuk L.A., Mutwiri G.K. Co-stimulation with TLR7/8 and TLR9 agonists induce down-regulation of innate immune responses in sheep blood mononuclear and B cells. Dev. Comp. Immunol. 2010, 34:572-578.
4. Booth J.S., Griebel P.J., Babiuk L.A., Mutwiri G.K. A novel regulatory B-cell population in sheep Peyer's patches spontaneously secretes IL-10 and downregulates TLR9-induced IFNalpha responses. Mucosal Immunol. 2009, 2:265-275.
5. Booth, J.S., Jimbo, S., Mutwiri, G.K., 2011. Novel Bregs downregulate TLR9-induced cytokine responses in sheep Peyer's patches. Vet. Immunol. Immunopathol., in press.
6. Booth J.S., Nichani A.K., Benjamin P., Dar A., Krieg A.M., Babiuk L.A., Mutwiri G.K. Innate immune responses induced by classes of CpG oligodeoxynucleotides in ovine lymph node and blood mononuclear cells. Vet. Immunol. Immunopathol. 2007, 115:24-34.
7. Brownlie R., Zhu J., Allan B., Mutwiri G.K., Babiuk L.A., Potter A., Griebel P. Chicken TLR21 acts as a functional homologue to mammalian TLR9 in the recognition of CpG oligodeoxynucleotides. Mol. Immunol. 2009, 46:3163-3170.
8. Creagh E.M., O'Neill L.A. TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. Trends Immunol. 2006, 27:352-357.
9. Dar M.A., Allan B., Gomis S., Potter A., Mutwiri G. Immunotherapeutic potential of CpG oligonucleotides in chickens. J. Poultry Sci. 2009, 46:69-80.
10. Davis H.L., Weeratna R., Waldschmidt T.J., Tygrett L., Schorr J., Krieg A.M., Weeranta R. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J. Immunol. 1998, 160:870-876.
11. Gavin A.L., Hoebe K., Duong B., Ota T., Martin C., Beutler B., Nemazee D. Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling. Science 2006, 314:1936-1938.
12. Gomis S., Babiuk L., Allan B., Willson P., Waters E., Ambrose N., Hecker R., Potter A. Protection of neonatal chicks against a lethal challenge of Escherichia coli using DNA containing cytosine-phosphodiester-guanine motifs. Avian Dis. 2004, 48:813-822.
13. Gomis S., Babiuk L., Godson D.L., Allan B., Thrush T., Townsend H., Willson P., Waters E., Hecker R., Potter A. Protection of chickens against Escherichia coli infections by DNA containing CpG motifs. Infect. Immun. 2003, 71:857-863.
14. Gramzinski R.A., Doolan D.L., Sedegah M., Davis H.L., Krieg A.M., Hoffman S.L. Interleukin-12- and gamma interferon-dependent protection against malaria conferred by CpG oligodeoxynucleotide in mice. Infect. Immun. 2001, 69:1643-1649.
15. Guzylack-Piriou L., Balmelli C., McCullough K.C., Summerfield A. Type-A CpG oligonucleotides activate exclusively porcine natural interferon-producing cells to secrete interferon-alpha, tumour necrosis factor-alpha and interleukin-12. Immunology 2004, 112:28-37.
16. Hashimoto C., Hudson K.L., Anderson K.V. The Toll gene of drosophila, required for dorso-ventral embryonic polarity appears to encode a transmembrane protein. Cell 1988, 52:269-279.
17. He H., Lowry V.K., Swaggerty C.L., Ferro P.J., Kogut M.H. In vitro activation of chicken leukocytes and in vivo protection against Salmonella enteritidis organ invasion and peritoneal S. enteritidis infection-induced mortality in neonatal chickens by immunostimulatory CpG oligodeoxynucleotide. FEMS Immunol. Med. Microbiol. 2005, 43:81-89.
18. Hornung V., Rothenfusser S., Britsch S., Krug A., Jahrsdorfer B., Giese T., Endres S., Hartmann G. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 2002, 168:4531-4537.
19. Ioannou X.P., Griebel P., Hecker R., Babiuk L.A., van Drunen Littel-van den Hurk S. The immunogenicity and protective efficacy of bovine herpesvirus 1 glycoprotein D plus Emulsigen are increased by formulation with CpG oligodeoxynucleotides. J. Virol. 2002, 76:9002-9010.
20. Ito S., Pedras-Vasconcelos J., Klinman D.M. CpG oligodeoxynucleotides increase the susceptibility of normal mice to infection by Candida albicans. Infect. Immun. 2005, 73:6154-6156.
21. Iwasaki A., Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 2004, 5:987-995.
22. Juffermans N.P., Leemans J.C., Florquin S., Verbon A., Kolk A.H., Speelman P., van Deventer S.J., van der Poll T. CpG oligodeoxynucleotides enhance host defense during murine tuberculosis. Infect. Immun. 2002, 70:147-152.
23. Klinman D.M., Conover J., Coban C. Repeated administration of synthetic oligodeoxynucleotides expressing CpG motifs provides long-term protection against bacterial infection. Infect. Immun. 1999, 67:5658-5663.
24. Klinman D., Takeshita F., Gursel I., Leifer C., Ishii K., Verthleyi D., Gursel M. CpG DNA; recognition by and activation of monocytes. Microbes Infect. 2002, 4:897-901.
25. Klinman D. Use of CpG oligodeoxynucleotides as immunoprotective agents. Expert Opin. Biol. Ther. 2004, 4:937-946.
26. Krieg A.M. CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 2002, 20:709-760.
27. Krieg A.M. Therapeutic potential of Toll-like receptor 9 activation. Nat. Rev. Drug Discov. 2006, 5:471-484.
28. Krieg A.M., Yi A.K., Matson S., Waldschmidt T.J., Bishop G.A., Teasdale R., Koretzky G.A., Klinman D.M. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995, 374:546-549.
29. Krug A., Rothenfusser S., Hornung V., Jahrsdorfer B., Blackwell S., Ballas Z.K., Endres S., Krieg A.M., Hartmann G. Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells. Eur. J. Immunol. 2001, 31:2154-2163.
30. Krutzik S., Ochoa M., Sieling P., Uematsu S., Ng Y., Liu P., Cole S., Godowski P., Maeda Y., Sarno E., Norgard M., Brennan P., Akira S., Rea T., Modlin R. Activation and regulation of Toll-like receptors 2 and 1 in human leprosy. Nat. Med. 2003, 9:525-532.
31. Lipford G.B., Sparwasser T., Zimmermann S., Heeg K., Wagner H. CpG-DNA-mediated transient lymphadenopathy is associated with a state of Th1 predisposition to antigen-driven responses. J. Immunol. 2000, 165:1228-1235.
32. Lopez A.M., Hecker R., Mutwiri G., van Drunen Littel-van den Hurk S., Babiuk L.A., Townsend H.G. Formulation with CpG ODN enhances antibody responses to an equine influenza virus vaccine. Vet. Immunol. Immunopathol. 2006, 114:103-110.
33. Medzhitov R., Janeway C. The Toll receptor family and microbial recognition. Trends Microbiol. 2000, 8:452-456.
34. Medzhitov R., Preston-Hurlburt, Janeway C.A. A human homologue of drosophila Toll protein signals activation of adaptive immunity. Nature 1997, 388:394-397.
35. Miettinen M., Saraneva T., Julkunen I., Matikainen S. IFNs activate Toll-like receptors in viral infections. Genes Immun. 2001, 2:349-355.
36. Mueller T., Terada T., Rosenberg I.M., Shibolet O., Podolsky D.K. Th2 cytokines down-regulate TLR expression and function in human intestinal epithelial cells. J. Immunol. 2006, 176:5805-5814.
37. Mutwiri G., Pontarollo R., Babiuk S., Griebel P., van Drunen Littel-van den Hurk S., Mena A., Tsang C., Alcon V., Nichani A., Ioannou X., Gomis S., Townsend H., Hecker R., Potter A., Babiuk L.A. Biological activity of immunostimulatory CpG DNA motifs in domestic animals. Vet. Immunol. Immunopathol. 2003, 91:89-103.
38. Mutwiri G., van Drunen Littel-van den Hurk S., Babiuk L.A. Approaches to enhancing immune responses stimulated by CpG oligodeoxynucleotides. Adv. Drug Deliv. Rev. 2009, 61:226-232.
39. Nemazee D., Gavin A., Hoebe K., Beutler B. Immunology: Toll-like receptors and antibody responses. Nature 2006, 441:E4. (discussion E4).
40. Nichani A.K., Dar M.A., Krieg A.M., Mirakhur K.K., Kaushik R.S., Griebel P.J., Manuja A., Townsend H.G., Babiuk L.A., Mutwiri G.K. Systemic innate immune responses following intrapulmonary delivery of CpG oligodeoxynucleotides in sheep. Vet. Immunol. Immunopathol. 2007, 115:357-368.
41. Nichani A.K., Dar M.A., Mirakhur K.K., Krieg A.M., Booth J.S., Townsend H.G., Potter A.A., Babiuk L.A., Mutwiri G.K. Subcutaneous, but not intratracheal administration of the TLR9 agonist, CpG DNA transiently reduces parainfluenza-3 virus shedding in newborn lambs. Comp. Immunol. Microbiol. Infect. Dis. 2010.
42. Nichani A.K., Mena A., Kaushik R.S., Mutwiri G.K., Townsend H.G., Hecker R., Krieg A.M., Babiuk L.A., Griebel P.J. Stimulation of innate immune responses by CpG oligodeoxynucleotide in newborn lambs can reduce bovine herpesvirus-1 shedding. Oligonucleotides 2006, 16:58-67.
43. Palm N.W., Medzhitov R. Immunostimulatory activity of haptenated proteins. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:4782-4787.
44. Pasare C., Medzhitov R. Control of B-cell responses by Toll-like receptors. Nature 2005, 438:364-368.
45. Querec T., Bennouna S., Alkan S., Laouar Y., Gorden K., Flavell R., Akira S., Ahmed R., Pulendran B. Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J. Exp. Med. 2006, 203:413-424.
46. Rice L., Orlow D., Ceonzo K., Stahl G.L., Tzianabos A.O., Wada H., Aird W.C., Buras J.A. CpG oligodeoxynucleotide protection in polymicrobial sepsis is dependent on interleukin-17. J. Infect. Dis. 2005, 191:1368-1376.
47. Ruprecht C.R., Lanzavecchia A. Toll-like receptor stimulation as a third signal required for activation of human naive B cells. Eur. J. Immunol. 2006, 36:810-816.
48. Sansonetti P.J. To be or not to be a pathogen: that is the mucosally relevant question. Mucosal Immunol. 2011, 4:8-14.
49. Sun S., Zhang X., Tough D.F., Sprent J. Type I interferon-mediated stimulation of T cells by CpG DNA. J. Exp. Med. 1998, 188:2335-2342.
50. Sparwasser T., Vabulas R.M., Villmow B., Lipford G.B., Wagner H. Bacterial CpG-DNA activates dendritic cells in vivo: T helper cell-independent cytotoxic T cell responses to soluble proteins. Eur. J. Immunol. 2000, 30:3591-3597.
51. Taghavi A., Allan B., Mutwiri G., Van Kessel A., Willson P., Babiuk L., Potter A., Gomis S. Protection of neonatal broiler chicks against Salmonella typhimurium septicemia by DNA containing CpG motifs. Avian Dis. 2008, 52:398-406.
52. Takeda K., Akira S. Microbial recognition by Toll-like receptors. J. Dermatol. Sci. 2004, 34:73-82.
53. Wilson H.L., Dar A., Napper S.K., Lopez M., Babiuk L.A., Mutwiri G.K. Int. Rev. Immunol. 2006, 25:183-213.
54. Yi A.K., Chang M., Peckham D.W., Krieg A.M., Ashman R.F. CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry. J. Immunol. 1998, 160:5898-5906.
55. Zeng X., Moore T.A., Newstead M.W., Deng J.C., Kunkel S.L., Luster A.D., Standiford T.J. Interferon-inducible protein 10, but not monokine induced by gamma interferon, promotes protective type 1 immunity in murine Klebsiella pneumoniae pneumonia. Infect. Immun. 2005, 73:8226-8236.
56. Zhu F.G., Marshall J.S. CpG-containing oligodeoxynucleotides induce TNF-alpha and IL-6 production but not degranulation from murine bone marrow-derived mast cells. J. Leukoc. Biol. 2001, 69:253-262.